Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1398, 2012-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Certolizumab pegol RAPIDly rising in RA
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :
Access to resources
Recommend
Certolizumab pegol dominates in the UK and Finland
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 617, 2010-01 ,pp. :
Certolizumab pegol: a guide to its use in Crohn's disease
Drugs & Therapy Perspectives, Vol. 23, Iss. 11, 2007-11 ,pp. :
Certolizumab pegol: Psoriatic skin lesions: case report
Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. :
Certolizumab pegol a PRECiSE treatment for Crohn's disease
Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. :